SEC Form 4 · accession 0001127602-18-035957
Alkermes plc. · ALKS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig C. Hopkinson
Officer — SVP, Med Dev/Med Affairs, CMO
Period of report
Dec 7, 2018
Accepted (ET)
Dec 11, 2018 · 7:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001520262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Dec 7, 2018 | A | 4,000 | $0.00 | A | 4,881 | D | |
| Ordinary Shares | Dec 7, 2018 | F | 1,178 | $34.01 | D | 3,703 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were acquired by the reporting person as a result of the partial vesting of performance-vesting restricted stock units granted to the reporting person on February 17, 2017. The vesting of this portion of the performance-vesting restricted stock units was triggered by ALKS 3831 achieving the pre-specified primary efficacy endpoints in each of two phase 3 studies.